AuDHD: Autism and ADHD Together

You already know the kitchen-table version: the same person can be autistic and have ADHD. The informal name for that is AuDHD. It is not a third diagnosis in the DSM-5, the manual many U.S. clinicians use. It is autism and ADHD named in the same person.

That is worth saying plainly because the two conditions share some day-to-day traits — attention that will not stay put, restlessness, a sensory load that fills a room — and those overlapping traits can hide one diagnosis behind the other. Clinicians call that diagnostic overshadowing: one label soaks up the symptoms, so the second condition never gets its own look. You can ask for both to be considered. You do not need a new invented category to do it.

Two diagnoses, not a third DSM category

Until 2013, DSM-IV made a dual diagnosis harder. The ADHD criteria treated autism as a reason not to diagnose ADHD. DSM-5 dropped that exclusion. The American Psychiatric Association’s own ADHD fact sheet is blunt: DSM-5 includes no exclusion criteria for people with autism spectrum disorder, because the symptoms co-occur. The World Health Organization’s ICD-11 moved the same way. Autism and ADHD can both be recorded when both sets of criteria are met.

That change did not invent a new condition and it did not start an epidemic. It let clinicians write down what many families and autistic adults already knew. You may still meet a clinic that “does one or the other.” That is usually how the local waitlist is built, not what the manuals require.

U.K. guidance is aligned. NICE, the National Institute for Health and Care Excellence, tells autism assessors to consider ADHD as a coexisting condition — a second condition that can sit alongside autism — and to carry out the right assessments if it is suspected. NICE also lists ADHD as a factor associated with a higher chance of autism, and it says that listing allows joint assessment when signs could belong to either condition. NICE’s ADHD guideline says ADHD should not be ruled out because of a pervasive developmental disorder, and that people with other neurodevelopmental conditions, including autism, may have a higher chance of ADHD.

The American Academy of Pediatrics says the same in pediatric care. Its 2020 autism report notes that ADHD may also be diagnosed in autistic children. Its 2019 ADHD guideline tells primary care clinicians to screen for coexisting developmental conditions, including autism, when they evaluate ADHD.

How common — keep each study on its own shelf

Co-occurrence is common. How common depends on who was counted, how ADHD was counted, and how old people were. Those numbers should stay on separate shelves. They are not one U.S. rate.

CDC’s Autism and Developmental Disabilities Monitoring Network estimated that 32.2 per 1,000 8-year-olds — about 1 in 31 — were identified with autism in 16 U.S. communities in 2022. That is an autism figure, not an AuDHD figure. The 2022 ADDM report did not publish a network-wide ADHD co-occurrence rate. Site estimates also ranged widely, from 9.7 per 1,000 in one Texas community to 53.1 per 1,000 in one California community, which is one reason a single national “how many” sentence is a poor fit.

An earlier ADDM analysis did look at ADHD in records. Soke and colleagues reviewed 4- and 8-year-olds identified with autism at five ADDM sites in 2010. ADHD was documented in 5.49% of the 4-year-olds (43 of 783) and 26.05% of the 8-year-olds (306 of 1,091). Those children were evaluated under older DSM-IV-TR rules, when dual diagnosis was harder, and “documented in the record” is not the same as a parent survey or a full clinical ADHD workup. The age gap is still useful: ADHD was much more often written down by age 8 than by age 4.

A later U.S. parent survey, after DSM-5, found a higher share. Casseus, Kim, and Horton pooled the 2016–2018 National Survey of Children’s Health. Among an estimated 1.7 million U.S. children with current autism, 43.8% (95% CI 38.8–48.9) also had current ADHD. Looked at the other way, among an estimated 5.3 million children with current ADHD, 13.9% (95% CI 12.1–15.7) also had current autism. Those are parent-reported current diagnoses, weighted to represent noninstitutionalized U.S. children. They are not interchangeable with ADDM record review.

Research reviews land in between, and they mix different kinds of samples. Rong and colleagues pooled 56 studies of current ADHD among autistic people and 13 studies of lifetime ADHD; they reported 38.5% current (95% CI 34.0–43.2) and 40.2% lifetime (95% CI 34.9–45.7). Age, intellectual disability, where people were recruited, and which diagnostic criteria were used all changed the current rate. Lai and colleagues, in a 2019 Lancet Psychiatry meta-analysis of 96 studies, reported a pooled ADHD prevalence of 28% (95% CI 25–32) among autistic people, with higher estimates in clinical samples than in population or registry samples. Mutluer and colleagues restricted their review to population-based studies of autistic children and adolescents published after DSM-5; they reported ADHD at 26.2% (95% CI 22–31) overall, 18.4% in children, and 35.4% in adolescents. Heterogeneity was high in all of these reviews. That is a statistics word for “the studies do not agree with each other as much as we wish they did.”

A 2020 expert consensus from the United Kingdom ADHD Partnership put the pattern in one sentence: in community samples, ADHD symptoms in autistic people are often reported around 28–31%; in clinical samples, 53–78%. A meta-analysis they cited of autistic traits in young people with ADHD found a comorbid rate of 21%. Clinic waiting rooms over-sample people with more complex needs. Population samples do not. Keep them apart.

When one label hides the other

Attention trouble, restlessness, and sensory overload can belong to autism, to ADHD, or to both. If the evaluator stops at the first label that fits, the second set of needs never makes it onto paper. That is diagnostic overshadowing — one diagnosis covering for another — and it is why “we already explained that” is not a complete answer.

The two conditions also pull in different directions on some days. Autistic people often need sameness and recovery time after sensory load. ADHD can bring a hunger for novelty and a hard time waiting. You can want a predictable routine and still not be able to start it. You can crave quiet and still not be able to sit still. None of that is a personality flaw, and none of it is a superpower you owe anyone.

 Soke’s ADDM analysis found that documented ADHD was linked with a later first autism evaluation among 8-year-olds, a pattern other researchers have also described: hyperactivity and inattention can mask social-communication differences, so autism is noticed later. The reverse happens too. An early autism diagnosis can soak up attention and organization problems that still meet ADHD criteria. Autistic girls and women, and people who do not fit a loud hyperactive picture, are especially easy to miss. NICE notes that autism may be under-recognized in girls, and that ADHD is thought to be under-recognized in girls and women, who are less often referred and more often given a different label first.

Casseus’s NSCH analysis is a reminder that the combination is not “the same, only more of one thing.” Compared with autistic children without ADHD, children with both had much higher parent-reported anxiety (60.0% vs 25.1%), depression (24.1% vs 7.1%), and behavior or conduct problems (69.6% vs 36.8%). Compared with children who had ADHD without autism, those with both still had higher anxiety, depression, and conduct problems, and much higher rates of developmental delay, intellectual disability, speech or language disorder, and learning disability. Nearly three-quarters (72.3%) of children with both were taking psychotropic medication — medicine for mood, attention, or behavior — versus 15.6% of autistic children without ADHD. Behavioral treatment rates were similar (59.9% vs 56.3%). That is a description of what families reported, not a prescription for what you should do.

What a careful evaluation can look like

A careful look at both conditions is not a personality test and it is not a 20-minute checklist. NICE’s autism pathway says an assessment should include developmental history, observation, differential diagnosis — a structured check of other explanations — and a systematic look at conditions that may coexist, including ADHD. NICE’s ADHD guideline says diagnosis should rest on a full clinical and psychosocial assessment, developmental history, and information from more than one setting, not on a rating scale alone.

The U.K. expert consensus is practical: when one condition is present, consider the other. Do not double-count the same behavior as proof of both. Talkativeness that is driven, loud, and jumping topics is not the same as talkativeness that is stuck on one interest and hard to redirect. Restlessness that eases when the person is absorbed in a special interest is a clue, not a trick. Adults who have spent years camouflaging — matching the room on purpose — may look “fine” in a short clinic visit and fall apart afterward. Ask for examples across home, school or work, and downtime. Ask what happens when the scaffolding comes off.

If you are an autistic adult seeking an ADHD evaluation, or an adult with ADHD who suspects autism, say so at the referral. Bring school reports if you have them, and a person who knew you as a child if that is safe and possible. The manuals now allow both. The waitlist software may not, unless you ask.

Medication, school plans, and what they do not do

This is not medical advice, and it is not a lawyer’s list. It is a set of questions you can take into the room.

ADHD medicines are for ADHD symptoms. They do not treat autism. There is no recommended medicine for the core social-communication and repetitive-behavior features of autism. NICE says people with ADHD and autism should be offered the same ADHD medication choices as other people with ADHD, with slower titration — a more gradual dose change — and closer monitoring when autism or another neurodevelopmental condition is also present. The American Academy of Pediatrics notes that medicine may be a useful addition for attention and hyperactivity as part of a broader plan, not as a stand-alone fix. If a clinician is considering medicine, ask whether both diagnoses are on the table, what the medicine is meant to change, and what will be watched. Ask what else is in the plan besides a pill.

School supports are separate from a medical diagnosis, though a diagnosis can help document need. The AAP ADHD guideline says educational interventions and individualized instructional supports are a necessary part of treatment and often include an Individualized Education Program (IEP) or a 504 plan — two different written school plans for instruction, accommodations, or both. Autism eligibility and ADHD-related needs are not automatically the same document. You can ask the team to look at attention, sensory load, transitions, and social communication as a set, not as a contest between labels. Ask what is in writing about breaks, reduced distraction, and how staff will tell the difference between “won’t” and “can’t start.”

Adults can ask workplaces and campuses about reasonable adjustments: quieter space, written follow-up after verbal instructions, flexible deadlines that still have a spine. Those are supports, not favors.

What to ask this week

Evaluation. Have you assessed for both autism and ADHD, or only the first label that fit? What information did you use from a second setting? If one was ruled out, what specifically did not meet criteria — and could camouflaging, intellectual profile, or sex have changed how it looked?

School. Which plan is in place, IEP or 504, and what does it actually say about attention, sensory input, and unstructured time? Who on the team has looked at both sets of needs? What will teachers do when work refusal is actually task initiation, the ADHD problem of not being able to start?

Clinician visit, if medicine is on the table. What symptoms is this meant to change, and which ones will it not change? How will autism-related sensory or sleep differences be watched? Who is coordinating the plan if more than one specialist is involved?

None of those questions require you to become a lawyer or a pharmacist. They require the people in the room to look at the whole person.

Sources

American Psychiatric Association. (2013). DSM-5 Attention Deficit/Hyperactivity Disorder fact sheet. https://www.psychiatry.org/File%20Library/Psychiatrists/Practice/DSM/APA_DSM-5-ADHD.pdf

Casseus, M., Kim, W. J., & Horton, D. B. (2023). Prevalence and treatment of mental, behavioral, and developmental disorders in children with co-occurring autism spectrum disorder and attention-deficit/hyperactivity disorder: A population-based study. Autism Research, 16(5). https://pmc.ncbi.nlm.nih.gov/articles/PMC10160807/

Centers for Disease Control and Prevention. (2026). Clinical care of ADHD in children. https://www.cdc.gov/adhd/hcp/clinical-care/index.html

Hyman, S. L., Levy, S. E., Myers, S. M., AAP Council on Children with Disabilities, & Section on Developmental and Behavioral Pediatrics. (2020). Executive summary: Identification, evaluation, and management of children with autism spectrum disorder. Pediatrics, 145(1), e20193448. https://depts.washington.edu/dbpeds/ExecutiveSummary.ID.Eval.Mgt.Children.ASD(AAP.2020).pdf

Lai, M.-C., Kassee, C., Besney, R., Bonato, S., Hull, L., Mandy, W., Szatmari, P., et al. (2019). Prevalence of co-occurring mental health diagnoses in the autism population: A systematic review and meta-analysis. The Lancet Psychiatry, 6(10), 819–829. https://www.thelancet.com/journals/lanpsy/article/PIIS2215-0366(19)30289-5/abstract

Mutluer, T., Aslan Genç, H., Özcan Morey, A., Yapici Eser, H., Ertinmaz, B., Can, M., & Munir, K. (2022). Population-based psychiatric comorbidity in children and adolescents with autism spectrum disorder: A meta-analysis. Frontiers in Psychiatry, 13, 856208. https://www.frontiersin.org/journals/psychiatry/articles/10.3389/fpsyt.2022.856208/full

National Institute for Health and Care Excellence. (2017/2011). Autism spectrum disorder in under 19s: Recognition, referral and diagnosis (CG128). https://www.nice.org.uk/guidance/cg128/chapter/recommendations

National Institute for Health and Care Excellence. (2018). Attention deficit hyperactivity disorder: Diagnosis and management (NG87). https://www.nice.org.uk/guidance/ng87/chapter/Recommendations

Rong, Y., Yang, C. J., Jin, Y., & Wang, Y. (2021). Prevalence of attention-deficit/hyperactivity disorder in individuals with autism spectrum disorder: A meta-analysis. Research in Autism Spectrum Disorders, 83, 101759. https://pure.ecnu.edu.cn/en/publications/prevalence-of-attention-deficithyperactivity-disorder-in-individu/

Shaw, K. A., Williams, S., Patrick, M. E., et al. (2025). Prevalence and early identification of autism spectrum disorder among children aged 4 and 8 years — Autism and Developmental Disabilities Monitoring Network, 16 sites, United States, 2022. MMWR Surveillance Summaries, 74(SS-2), 1–22. https://www.cdc.gov/mmwr/volumes/74/ss/ss7402a1.htm

Soke, G. N., Maenner, M. J., Christensen, D., Kurzius-Spencer, M., & Schieve, L. A. (2018). Prevalence of co-occurring medical and behavioral conditions/symptoms among 4- and 8-year-old children with autism spectrum disorder in selected areas of the United States in 2010. Journal of Autism and Developmental Disorders, 48(8), 2663–2676. https://stacks.cdc.gov/view/cdc/56976/cdc_56976_DS1.pdf

Wolraich, M. L., Hagan, J. F., Jr., Allan, C., et al. (2019). Clinical practice guideline for the diagnosis, evaluation, and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Pediatrics, 144(4), e20192528. https://stacks.cdc.gov/view/cdc/85858/cdc_85858_DS1.pdf

Young, S., Hollingdale, J., Absoud, M., et al. (2020). Guidance for identification and treatment of individuals with attention deficit/hyperactivity disorder and autism spectrum disorder based upon expert consensus. BMC Medicine, 18, 146. https://link.springer.com/article/10.1186/s12916-020-01585-y

Subscribe to Autism Digest for research-backed guides written for parents and autistic adults.